MedTrace Logo

Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain

NCT06574451 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2024-08-28

No results posted yet for this study

Summary

A randomized controlled, prospective, multicenter, open label, superiority trial aims to evaluate the effectiveness and safety of adjuvant software based on virtual reality for post-thoracoscopic surgery pain.

Conditions

  • Acute Postoperative Pain
  • Video-assisted Thoracic Surgery
  • Virtual Reality

Interventions

DEVICE

VR-assisted postoperative analgesia

Patients will receive postoperative analgesic adjunctive therapy software to assist in pain control, with one postoperative analgesic adjunctive therapy software intervention at 24 hours and 48 hours after surgery, and pain evaluation within 30 minutes.

Sponsors & Collaborators

  • Guang Dong Liang Zi Health Consulting Co., Ltd, Guang Dong, China.

    collaborator UNKNOWN

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Maoming People's Hospital

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Wen-Zhao Zhong · Guangdong Provincial People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-22
Primary Completion
2025-04-24
Completion
2025-04-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06574451 on ClinicalTrials.gov